Ospedale Universitario Marqués de Valdecilla
Welcome,         Profile    Billing    Logout  
 3 Trials 
5 Trials

   

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Hernandez, Jose M
ECHELON-3, NCT04404283 / 2020-002686-33: Brentuximab Vedotin Plus Lenalidomide and Rituximab for the Treatment of Relapsed/Refractory DLBCL

Hourglass Jan 2023 - Dec 2023 : From:ECHELON-3 trial in combination with brentuximab vedotin and rituximab for r/r DLBCL
Active, not recruiting
3
240
Europe, Canada, US, RoW
Brentuximab vedotin, Rituximab, Lenalidomide, Placebo
Seagen Inc.
Diffuse Large B-cell Lymphoma
05/25
04/27
NOAHS-ARC, NCT04864067: No Operation After Short Course Radiotherapy Followed By Consolidation Chemotherapy In Locally Advanced Rectal Cancer

Recruiting
2
73
RoW
Oxaliplatin, All Brands, 5-Fluoracil, Leucovorin, Capecitabine, 5x5 Gy, Quality of Life Questionnaires, DRE/ Endoscopy
Servicio de Salud Metropolitano Sur Oriente
Rectal Cancer
12/24
05/25
STARLIGHT, NCT06613698: A Study to Investigate the Safety and Efficacy of GSK4532990 Compared With Placebo in Adult Participants Aged 18 to 65 Years With Alcohol-related Liver Disease

Not yet recruiting
2
393
Europe, Canada, Japan, US, RoW
GSK4532990, Placebo
GlaxoSmithKline
Liver Diseases, Alcoholic
12/26
03/27
RIGHT-MARE, NCT05713201: Outcomes After PCI of the Aneurysmatic Right Coronary Artery

Recruiting
N/A
90
Europe
Percutaneous Coronary Intervention
San Luigi Gonzaga Hospital
Coronary Disease, Coronary Artery Ectasia, Right Coronary Artery Occlusion, Right Coronary Artery Stenosis, STEMI
04/24
12/24
NCT05114850: Retrospective Prospective Multicentric Clinical Follow up of Patients After Being Treated With TricValve®

Recruiting
N/A
450
Europe
P+F Products + Features GmbH
Tricuspid Regurgitation, Tricuspid Valve Insufficiency, Tricuspid Insufficiency, Heart Failure, Heart Diseases, Heart Valve Diseases
12/25
12/28

Download Options